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Partial least squaresAbstract A quantitative structure activity relationship study was performed on a series of uracil
based hydroxamide Inhibitors of maize deacetylases HD2 and histone deacetylase (Mouse HDAC1)
activity for establishing quantitative relationship between biological activity and their physicochem-
ical properties. The two dimensional and k-nearest neighbor studies were performed using partial
least square methodology coupled with genetic algorithm (GA) and simulated annealing (SA)
was applied to derive models. The 2D model developed gave good correlation coefﬁcient (r2) of
0.8498, and r2 for external test set (pred_r2) 0.7932 was developed by GA-PLS with the descriptors
such as Hydrogen count, SsssCHcount, and SdsCHE-index. k-nearest neighbor method was applied
for the generation of steric and electrostatic descriptors based on aligned structures. 3D QSAR
studies produced reasonably good predictive models with high cross-validated q2 value of 0.679
and pred_r2 = 0.733 values using the model GA kNN-MFA method. The best pharmacophore
shows that the four features used were one AroC feature (Aromatic), one AlaC (aliphatic) and
two HAc (Hydrogen bond acceptor) features. The average RMSD of the pharmacophore alignment
of each two molecules is 0.0754 A˚. The QSAR result gives relationship between structural
Uracil-based hydroxamic acids derivatives and their activities which should be useful to design
newer histone deacetylase inhibitors.
ª 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Histone deacetylases (HDACs) represent a family of enzymes
that compete with histone acetyltransferases (HATs) to modu-
late chromatin structure and transcriptional activity via change
in acetylation status of nucleosomal histones. HDACs are
deacetylating the e-amino groups of lysine located near
the amino termini of core histone proteins (Monneret, 2005;hibitors.
2 M.C. Sharma, S. SharmaMai et al., 2002). To date, four classes of mammalian HDACs
are known according to their homology with the correspond-
ing yeast transcriptional regulators. Class I (HDAC1-3,8),
IIa (HDAC4,5,7,9), IIb (HDAC6,-10), and IV (HDAC11)
HDACs are Zn2+-dependent deacetylases, are components
of multiprotein complexes containing other proteins known
to function in transcriptional activation/repression, and differ
for their subcellular localization and tissue expression
(Grozinger and Schreiber, 2002; Gregoretti et al., 2004;
Verdin et al., 2003). Acetylation and deacetylation of the speci-
ﬁc lysines within histones play a crucial role in the transcrip-
tional process (Pazin and Kadonaga, 1997). Two families of
enzymes, acetylases and deacetylases, are involved in control-
ling the acetylation state of histones. Histone deacetylase
(HDAC) enzymes, which regulate the level of histone acetyla-
tion, are one of the major groups mediating epigenetic control.
HDAC enzymes act by regulating the level of biological acety-
lation and deacetylation reactions of their targets. Acetylation
of the N-terminal region of histone proteins promotes gene
expression (Garea and Esteller, 2004; Somech et al., 2004).
Recent studies show that inhibition of histone deacetylases
elicits anticancer effects in several tumor cells by inhibition
of cell growth and induction of cell differentiation. The
development of HDAC inhibitors as anticancer drugs has been
initiated, and compounds such as the hydroxamic acid
Trichostatin A (TSA) (Yoshida et al., 1990) suberanilohydrox-
amic acid (Richon et al., 1998) the cyclic tetrapeptides apicidin
(Han et al., 2000) and trapoxin, (Kijima et al., 1993) as well as
synthetic inhibitors have been studied for this purpose in
cancer cell lines. Thus, inhibition of HDACs, which induces
histone hyperacetylation, provides a potential target for the
development of synthetic anticancer drugs (Bouchain et al.,
2001; Curtin and Glaser, 2003; Weinmann and Ottow, 2004).
Histone deacetylase inhibitors (HDACis) exert cell type –
speciﬁc effects including apoptosis, cell-cycle arrest and differ-
entiation. In leukemias, HDACis include the expression of
members of the tumor-necrosis factor-related apoptosis-
inducing ligand and FAS death receptor pathways. This
induction is responsible for the pro-apoptotic efforts of
HDACis (Johnstone, 2002; Marks et al., 2001; Insinga et al.,
2005; Nebbioso et al., 2005). Cell-based studies have shown
that HDACIs have a powerful antiproliferative property,
causing cell-cycle arrest, apoptosis, and differentiation; these
antiproliferative effects are far more pronounced in tumor cells
than in normal cells (Inche and La Thangue, 2006). HDACs
have increasingly become important targets and the hunt for
HDAC inhibitors has been intensiﬁed and attracted great
attention in drug discovery over the years (Pandolﬁ, 2001).
2D-QSAR relationship is a rough approximation and contains
topological or two-dimensional (2D) information. It explains
how the atoms are bonded in a molecule, the type of bonding,
and the interaction of particular atoms (e.g., total path count,
molecular connectivity indices, etc.). The pharmacophore
modeling is a well established approach to quantitatively
explore common chemical features among a considerable num-
ber of structures and qualiﬁed pharmacophore model could
also be used as a query for searching chemical databases to
ﬁnd new chemical entities (Sotriffer et al., 1996).
The present work is an attempt to generate predictive
QSAR models based on 2D and 3D-QSAR methods and to
ﬁnd the structural features of uracil-based hydroxamic acids
required for histone deacetylase inhibitor activities to guidePlease cite this article in press as: Sharma, M.C., Sharma, S. Molecular modeling st
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In this investigation, widely used technique, viz., genetic
algorithm (GA) and simulated annealing (SA) has been
applied for descriptor optimization, and kNN-MFA analysis
has been applied for 3D-QSAR model development.
2. Materials and methods
2.1. Dataset for analysis
A data set of thirty-four N-hydroxy-polymethylenealkanamide
group (uracil-based hydroxamic acids) derivatives of reported
series for histone deacetylase inhibitors was used for the
present QSAR study (Mai et al., 2006). The biological activity
values [IC50 (nM)] reported in the literature were converted to
their molar units and then further to negative logarithmic scale
(pIC50) and subsequently used as the dependent variable for
the QSAR analysis. Table 1 shows the structure of 34 such
compounds along with their biological activity values.
2.2. Selection of training and test set
The total set of 34 compounds was divided into a training set
(27 compounds) for generating 2D QSAR models and a test set
(7 compounds) for validating the quality of the models
(Table 1). Selection of the training set and test set molecules
was done on the basis of structural diversity and a wide range
of activity such that the test-set molecules represent a range of
biological activity similar to that of the training set; thus, the
test set is truly representative of the training set (Golbraikh
and Tropsha, 2002). The unicolumn statistics of the training
and test sets is reported in Table 2. The maximum and mini-
mum values in training and test set were compared in a way
that:
1. The maximum value of pIC50 of test set should be less than
or equal to maximum value of pIC50 of training set.
2. The minimum value of pIC50 of test set should be higher
than or equal to minimum value of pIC50 of training set.
This observation showed that test set was interpolative and
derived within the minimum–maximum range of training set.
The mean and standard deviation of pIC50 values of sets of
training and test provide insights into the relative difference
of mean and point density distribution (along mean) of the
two sets (VLife MDS, 2008).
2.3. Calculation of 2D-QSAR descriptors
The molecular structures of all the 34 molecules were built
using the 2D draw application of V-Life MDS 3.5 software
(VLife MDS, 2008) with standard bond lengths and bond
angles. Geometry optimization was carried out using the
standard Merck Molecular Force Field (MMFF) followed
by considering distance-dependent dielectric constant of 1.0,
convergence criterion or root-mean-square (RMS) gradient
at 0.01 kcal/mol A˚ and the iteration limit to 10,000 (Halgren,
1996). The energy-minimized geometry was used for the calcu-
lation of the molecular descriptors.
A total of 264 descriptors were calculated by using VLife
Sciences Molecular Design Suite which was subsequentlyudy of uracil-based hydroxamic acids-containing histone deacetylase inhibitors.
Table 1 Structure, and biological activity of uracil-containing histone deacetylase inhibitors.
N
NH
S
X
O
NHOH
O
R
Com. no. R X IC50 pIC50
1 Ph (CH2)2 822 2.914
2 Ph (CH2)3 27 1.431
3a Ph (CH2)4 8 0.903
4 Ph (CH2)5 12 1.079
5 Ph (CH2)6 38 1.579
6 Ph (CH2)7 42 1.623
7 Ph 367 2.564
8 Ph 17 1.230
9a Ph 23 1.361
10 Ph CH2 CH‚CH 9000 3.954
11a Ph CH2 (CH2)2 38 1.579
12 Ph CH2 (CH2)3 229 2.359
13 Ph CH2 (CH2)4 125 2.096
14 Ph CH2 (CH2)5 18 1.255
15a PhCH(CH3) (CH2)5 9 0.954
16 PhCH(C2H5) (CH2)5 32 1.505
17 PhCH(OCH3) (CH2)5 82 1.913
18 (CH2)5 62 1.792
19 PhCH(Ph) (CH2)5 52 1.716
20a PhCH2 (CH2)6 37 1.568
21 PhCH2 (CH2)7 61 1.785
22 PhCH2 760 2.880
(continued on next page)
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Figure 1a Common template view for aligned molecules.
Table 1 (continued)
Com. no. R X IC50 pIC50
23a PhCH2 41 1.612
24 PhCH2 80 1.903
25 PhCH2CH2 CH‚CH 41,000 4.612
26a PhCH2CH2 (CH2)2 37 1.568
27 PhCH2CH2 (CH2)3 205 2.311
28 PhCH2CH2 (CH2)4 40 1.602
29 PhCH2CH2 (CH2)5 35 1.544
30 PhCH2CH2 (CH2)6 83 1.919
31 PhCH2CH2 (CH2)7 90 1.954
32 H (CH2)5 213 2.328
33 Me (CH2)5 110 2.041
34 n-Pr (CH2)5 135 2.130
a The compounds considered in the test set in 2D QSAR and 3D QSAR.
Table 2 Unicolumn statistics of the training and test sets for
activity.
Data set Average Max Min Std. dev. Sum
Training 1.9377 4.6128 0.9031 0.8995 44.563
Test 1.8140 2.5647 1.2304 0.4617 14.5122
4 M.C. Sharma, S. Sharmareduced to 231 descriptors. The descriptors having the same
value or almost same value or highly correlated with other
descriptors were removed initially. For calculation of AI
descriptors (Baumann, 2002) every atom in the molecule was
assigned at least one and at most three attributes.
In this study to calculate AI descriptors, we have used fol-
lowing attributes, 2 (double bonded atom), 3 (triple bonded
atom), C, N, O, S, H, F, Cl, Br and I and the distance range
of 0–7. A value of pred_r2 greater than 0.5 indicates the good
predictive capacity of the QSAR model. However, a QSAR
model is considered to be predictive, if the following condi-
tions are satisﬁed: r2 > 0.6, q2 > 0.6 and pred_r2 > 0.5
(Golbraikh and Tropsha, 2002).
2.4. Calculation of 3D-QSAR descriptors
Energy minimized and geometry optimized structure of mole-
cules were aligned by the template-based method (Ajmani
et al., 2006). The template structure, i.e., Uracil-based 2-phe-
nylethyl moiety ring was used for alignment by considering
the common elements of the series as shown in Fig. 1a. The
compound 8 possessed very high Histone deacetylase activity
which made it a valid lead molecule and therefore was chosenPlease cite this article in press as: Sharma, M.C., Sharma, S. Molecular modeling st
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shown in Fig. 1b.
For calculation of ﬁeld descriptor values, using Tripos force
ﬁeld (Clark et al., 1989), steric, electrostatic and hydrophobic
ﬁeld types, with cutoffs of 10.0 and 30.0 kcal/mol, were select-
ed and charge type was selected as by Gasteiger and Marsili
(1980). The k-nearest neighbor ﬁeld depicting the steric, electro-
static and hydrophobic interaction with methyl probe with
+1.0 charges was calculated using MMFF. This resulted inudy of uracil-based hydroxamic acids-containing histone deacetylase inhibitors.
Figure 1b Molecular alignment of the compounds.
Molecular modeling study of histone deacetylase inhibitors 5calculation of 7500 ﬁeld descriptors (2500 for each steric, elec-
trostatic and hydrophobic which theoretically form a con-
tinuum) for all the compounds in separate columns after
removing descriptors having zero values or same values
(Table 3).Table 3 Selected descriptor parameters of uracil-containing histone
Hydrogen count SsCH3E-index SssCH2count
13 1 0
17 1 3
19 2 2
13 1 1
21 3 1
23 2 4
25 3 3
23 3 2
23 0 5
23 2 1
15 0 3
23 3 2
23 1 6
25 2 3
25 2 3
25 2 3
17 1 2
15 1 2
17 1 3
19 1 4
21 2 3
15 0 3
23 3 2
25 4 1
15 0 3
17 0 4
17 1 5
19 0 5
21 1 3
15 1 3
23 1 3
17 1 0
19 1 3
21 2 2
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This study was performed using the software package VLife
MDS 3.5. Mol-Sign Module is used for the identiﬁcation, gen-
eration and analysis of pharmacophore by aligning small
organic molecules based on their 3D pharmacophore features.
For four point pharmacophore identiﬁcation tolerance limit
set up to 30 A˚ and max distance allowed between two features,
set the value to 5 A˚.
2.6. Model validation
Internal validation was carried out using leave-one-out (q2,
LOO) method (Cramer et al., 1988). To calculate q2, each
molecule in the training set was sequentially removed, the
model reﬁt using same descriptors, and the biological activity
of the removed molecule predicted using the reﬁt model. The
q2 was calculated using Eq. (1):
q2 ¼ 1
P ðyi  y^iÞ2
P ðyi  ymeanÞ2
ð1Þ
where yi; y^i are the actual and predicted activity of the ith
molecule in the training set, respectively, and ymean is the aver-
age activity of all molecules in the training set. For externaldeacetylase inhibitors.
E_685 S_1300 S_723
4.06345 0.0815 0.03115
2.55971 0.06849 0.02768
3.11461 0.08471 0.03474
3.15068 0.08472 0.03406
3.57275 0.0712 0.02986
5.44394 0.09349 0.04915
4.19008 0.07958 0.03186
2.59508 0.08244 0.03261
2.60821 0.0899 0.03615
2.56547 0.07972 0.0327
4.12765 0.08894 0.0361
3.71669 0.08671 0.0366
3.22463 0.085 0.03714
2.4758 0.06276 0.02702
3.33551 0.06843 0.02764
3.18016 0.08759 0.03677
3.66436 0.08232 0.03333
3.62527 0.08294 0.03473
3.68885 0.08395 0.0353
3.96116 0.08559 0.0371
4.20193 0.0731 0.03209
4.12765 0.08894 0.0361
2.98852 0.07692 0.03137
2.14352 0.06539 0.0268
4.4181 0.08737 0.03551
3.78845 0.08891 0.03611
4.06963 0.08798 0.0371
4.07541 0.09274 0.04239
4.69453 0.07144 0.02849
4.12338 0.06524 0.02716
1.700023 0.05866 0.0249
4.06345 0.05951 0.12278
2.55971 0.06875 0.13092
3.11461 0.05554 0.11523
udy of uracil-based hydroxamic acids-containing histone deacetylase inhibitors.
Figure 1d Contribution charts of the descriptors for the 2D
Models 1 and 2.
6 M.C. Sharma, S. Sharmavalidation, activity of each molecule in the test set was predict-
ed using the model generated from the training set. The pred_r2
value is calculated as follows (Eq. (2)):
pred r2 ¼ 1
P ðyi  y^iÞ2
P ðyi  ymeanÞ2
ð2Þ
where yi; y^i are the actual and predicted activity of the ith
molecule in the test set, respectively, and ymean is the average
activity of all molecules in the training set.
3. Results and discussions
The 2D- and 3D-QSAR studies of 34 Uracil-based hydroxamic
acids derivatives for inhibitory histone deacetylase inhibitors
through PLS and k-nearest neighbor methodology,
respectively.
3.1. Interpretations of 2D QSAR models
pIC50 = 0.4820 (±0.0946) Hydrogen count 0.1235 (±0.0832)
SdsCHE-index +0.0915 (±0.0046) T_2_C_1+ 1.1446
(±0.3452) SsssCHcount +0.1406 (±0.0658) SsCH3E-index.
Degrees of Freedom = 20, Ntraining = 27, Ntest = 7,
r2 = 0.8498, q2 = 0.7639, F test = 57.2652, r2_se = 0.3274,
q2_se = 0.3762, pred_r2 = 0.7932, pred_r2se = 0.3276, Z score
Q^2 = 1.33392, Best Rand Q^2 = 0.96451.
The statistically signiﬁcant penta-parametric model with
GA-PLS method with coefﬁcient of determination (r2) =
0.8498 is capable of explaining 84.98% of variance in the
observed activity values. The low standard error of
r2_se = 0.2274 demonstrates accuracy of the model. Cross-
validated squared correlation coefﬁcient of this model was
0.7639% which shows the good internal prediction power of
this model. Another parameter for predictivity of test set
compound is high pred_r2 = 0.7932 which is showing good
external predictive power of the model.
Model 1 is obtained by the GA-PLS method which shows
positive contribution of Hydrogen count, T_2_C_1, SsssCH-
count, SsCH3E-index and a negative correlation with
SdsCHE-index. The positive coefﬁcient associated with the
SsCH3E-index descriptor in the model suggests that the
increased number of eCH3 will augment the potency of
the compounds. Positive contribution of this descriptor
revealed the increase of histone deacetylase inhibitors of
Uracil-based with the presence of CH3 group. The higherFigure 1c Plot of observed versus predicted activity by 2D
QSAR GA-PLS Model-1.
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this ﬁnding. The descriptor hydrogen count descriptor indices
for number of hydrogen atoms will augment the potency of the
compounds. The descriptor T_2_C_1 indicates that the pres-
ence of substituents with direct attachment of carbon on aro-
matic ring (i.e., ACH3 or AC2H5) favorable for the activity.
Positive contributions of these descriptors were clearly signify-
ing that the presence of uracil pharmacophore was important
for biological activity. The SaaCHcount [the total number of
carbon atoms connected with hydrogen along with two aro-
matic bonds] is 28% positively contributing descriptor toward
activity. SdsCHE-index is [electrotopological state index for
number of ACH group connected] with one double and one
single bond, i.e., aryl/alkyl atom types. The above model is
validated by predicting the biological activities of the test
molecules, as indicated in Table 5. The graph for observed ver-
sus predicted activity and contribution chart for Model 1 is
shown in Figs. 1c and 1d respectively. The correlation matrix
is shown in Table 4 which shows good correlation of selected
parameters with biological activity.
pIC50 =0.4486 (±0.0917) s logP+0.6310 (±0.2815)
SssCH2count +0.0367 (±0.0047) T_2_T_6+ 0.0576 (±0.0037)
Rotatable Bond Count 0.0036.
Degrees of Freedom = 20, Ntraining = 27, Ntest = 7,
r2 = 0.7614, q2 = 0.6632, F test = 33.2158, r2se = 0.4036,
q2se = 0.3502, pred_r2 = 0.7229, pred_r2se = 0.5206, Z score
Q^2 = 2.33343, Best Rand Q^2 = 1.57212.
The signiﬁcant Model 2 using the GA-PLS analysis method
having 0.7614 as the coefﬁcient of determination (r2) was con-
sidered and explains 76.14% of the variance in the observed
activity values. It shows an internal predictive power
(q2 = 0.6632) of 66% and a predictivity for the external test
set (pred_r2 = 0.7229) of about 72%. The GA-PLS model
indicated that the descriptor SssCH2count, Rotatable Bond
Count, alignment-independent descriptor contribute positively
T_2_T_6 and, s logP contributes negatively.
GA-PLS model reveals that the descriptor is rotatable bond
count positive coefﬁcient shows that increase in rotatable
bonds in compounds is detrimental for the activity. This sug-
gests that the presence of less number of rotatable bonds in
compounds would increase the activity (like in compound 2–
6; 11–21 and 26–34) in at X position of uracil moiety favored
the activity. Model shows that the descriptor SssCH2count
plays most important role (36%) in determining activity.
The positive correlation suggests that histone deacetylase inhi-
bitors of uracil derivatives may be increased by increasing the
number of such ACH2 groups present in the molecules. Theudy of uracil-based hydroxamic acids-containing histone deacetylase inhibitors.
Table 5 Comparative observed and predicted activities of uracil-derivatives.
Com. pIC50 2D Model-1 2D Model-3 3D Model-5 3D Model-6
Pred. Res. Pred. Res. Pred. Res. Pred. Res.
1 2.914 2.949 0.035 2.894 0.02 2.923 0.009 2.902 0.012
2 1.431 1.443 0.012 1.417 0.014 1.471 0.04 1.402 0.029
3 0.903 0.886 0.017 0.921 0.018 0.883 0.02 0.932 0.029
4 1.079 1.063 0.016 1.115 0.036 1.014 0.065 1.052 0.027
5 1.579 1.529 0.05 1.5411 0.0379 1.613 0.034 1.541 0.038
6 1.623 1.589 0.034 1.594 0.029 1.685 0.062 1.659 0.036
7 2.564 2.472 0.092 2.593 0.029 2.525 0.039 2.607 0.043
8 1.230 1.186 0.044 1.281 0.051 1.112 0.118 1.159 0.071
9 1.361 1.409 0.048 1.333 0.028 1.451 0.09 1.345 0.016
10 3.954 3.904 0.05 3.890 0.064 3.971 0.017 3.915 0.039
11 1.579 1.614 0.035 1.534 0.045 1.583 0.004 1.533 0.046
12 2.359 2.316 0.043 2.394 0.035 2.253 0.106 2.296 0.063
13 2.096 2.113 0.017 2.137 0.041 2.122 0.026 2.040 0.056
14 1.255 1.204 0.051 1.261 0.006 1.230 0.025 1.274 0.019
15 0.954 0.990 0.036 0.982 0.028 0.992 0.038 0.973 0.019
16 1.505 1.543 0.038 1.541 0.036 1.432 0.073 1.461 0.044
17 1.913 1.850 0.063 1.949 0.036 1.922 0.009 1.874 0.039
18 1.792 1.833 0.041 1.764 0.028 1.742 0.05 1.727 0.065
19 1.716 1.668 0.048 1.746 0.03 1.762 0.046 1.737 0.021
20 1.568 1.601 0.033 1.505 0.063 1.545 0.023 1.554 0.014
21 1.785 1.842 0.057 1.706 0.079 1.716 0.069 1.791 0.006
22 2.880 2.868 0.012 2.831 0.049 2.852 0.028 2.863 0.017
23 1.612 1.653 0.041 1.663 0.051 1.575 0.037 1.737 0.125
24 1.903 1.936 0.033 1.944 0.041 1.947 0.044 1.000 0.903
25 4.612 4.665 0.053 4.591 0.021 4.678 0.066 4.635 0.023
26 1.568 1.603 0.035 1.447 0.121 1.517 0.051 1.547 0.021
27 2.311 2.334 0.023 2.292 0.019 2.387 0.076 2.245 0.066
28 1.602 1.668 0.066 1.575 0.027 1.589 0.013 1.635 0.033
29 1.544 1.559 0.015 1.498 0.046 1.577 0.033 1.535 0.009
30 1.919 1.996 0.077 1.883 0.036 1.869 0.05 1.936 0.017
31 1.954 2.000 0.046 1.989 0.035 1.916 0.038 1.978 0.024
32 2.328 2.302 0.026 2.292 0.036 2.366 0.038 2.307 0.021
33 2.041 2.118 0.077 2.019 0.022 2.113 0.072 2.154 0.113
34 2.130 2.167 0.037 2.086 0.044 2.174 0.044 2.091 0.039
Res. = Obs. pIC50 – Pred. pIC50.
Table 4 Correlation matrix between descriptors present in the best QSAR Model-1.
Parameter H-Count SdsCHE-index T_2_C_1 SsssCHcount SsCH3E-index
H-Count 1.0000
SdsCHE-index 0.5432 1.0000
T_2_C_1 0.3291 0.5492 1.0000
SsssCHcount 0.3948 0.5874 0.6574 1.0000
SsCH3E-index 0.2873 0.4392 0.6148 0.7728 1.0000
Molecular modeling study of histone deacetylase inhibitors 7descriptor s logP (24%) which is directly proportional to the
activity and shows the role of thermodynamic property in
determining activity. The descriptor T_2_T_6 (i.e., pair of
any double bonded atom with any atom separated by six
bonds) plays most important role in activity, which mainly
indicates the relationship with reference to variation in differ-
ent substitution patterns (mono, di, tri) on the phenyl ring.
pIC50=0.8928 (±0.2301) Carbons Count+ 0.4796
(±0.1410) SsCH3E-index+ 0.8290 (±0.2880) SsssCHE+ 0.1208
(±0.0534) SaasCE-index
Degrees of Freedom = 23, Ntraining = 27, Ntest = 7,
r2 = 0.8524, q2 = 0.7750, F test = 42.6705, r2se = 0.3340,Please cite this article in press as: Sharma, M.C., Sharma, S. Molecular modeling st
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Q^2 = 2.42160, Best Rand Q^2 = 1.82987.
Model-3 shows good correlation between biological activity
and parameters Carbons Count, SsCH3E-index, SsssCHE and
SaasCE-index as the correlation coefﬁcient r2 = 0.8524 and
the model explains about 85% variance in activity by uracil
derivatives. The model shows an internal predictive
(q2 = 0.7750) of 77% and a predictivity for the external test
(pred_r2 = 0.7447) of 74%.
SA-PLS model reveals that the SaasCE-index [electrotopo-
logical state index for number of carbon atoms connected with
one single bond along with two aromatic bonds] positiveudy of uracil-based hydroxamic acids-containing histone deacetylase inhibitors.
Figure 1e Contribution plot for steric and electrostatic interactions 3D QSAR GA-PLS model.
Figure 1f Plot of observed versus predicted activity by best 3D
QSAR model.
8 M.C. Sharma, S. Sharmacorrelation (16%) of the descriptor in the model indicates
that the carbon atoms connected with aromatic rings and sin-
gle bonds positively inﬂuence activity shown by substituted
uracil derivatives. The SsssCHE (19.40%) is a topological
index, and signiﬁes total number of ACH groups connected
with three single bonds. The descriptor suggests that activity
can be achieved by increasing the saturated rings and saturated
aliphatic chains. The positive coefﬁcient of SsCH3E-index
(26.66%) showed that increase methyl group is detrimental
for the inhibitory activity against Histone deacetylase (like in
compounds 1–6; 11–21 and 26–34). The descriptor Carbon
Count signiﬁes the number of carbon atoms in a compound.
This provides carbon atoms in the molecule with a particular
arrangement that are responsible for the activity. The above
model is validated by predicting the biological activities of
the test molecules, as indicated in Table 5.
pIC50 = 1.5252 (±0.2431) SssOE-index 0.0408
(±0.0130) Quadrupole2 + 0.3485 (±0.1179) SssCH2E-index.
Degrees of Freedom = 20, Ntraining = 27, Ntest = 7,
r2 = 0.7325, q2 = 0.6879, F test = 14.7508, r2se = 0.3316,
q2se = 0.4572, pred_r2 = 0.7008, pred_r2se = 0.2211, Z score
Q^2 = 1.58084, Best Rand Q^2 = 1.18505.
Model 4 generated using SA-PLS method with 0.7325, as
the coefﬁcient of determination (r2) was considered using the
same molecules in the test and training sets. The model can
explain 73% of the variance in the observed activity values.
The model shows an internal predictive power (q2 = 0.6879)
of 69% and predictivity for the external test set
(pred_r2 = 0.7008) of about 65%. Model 4 also shows a posi-
tive correlation with SssOE-index, SssCH2E-index, and a nega-
tive correlation with Quadrupole2.
The descriptor SssOE-index which is electrotopological
state indices for number of oxygen atom connected with two
single bonds showed positive contribution with contribution
of 48.15%. This diminishing inﬂuence is augmented by the
presence of O-Me groups at the R position. The other descrip-
tor SssCH2E-index, which signiﬁes estate contributions deﬁn-
ing electrotopological state indices for the number of CH2
groups attached to two single bonds, also showed a positive
contribution (25.92%). The descriptor Quadrupole2 which
carries a negative sign in this model meaning that the
decreased Quadrupole of the molecule decreases the activity.Please cite this article in press as: Sharma, M.C., Sharma, S. Molecular modeling st
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In present investigation, two widely used techniques, viz.,
genetic algorithm (GA) and simulated annealing (SA) have
been applied for descriptor optimization.
The q2, pred_r2, Vn and k value of kNN-MFA with GA and
SA were (0.6790, 0.7339, 4/4) and (0.6538, 0.6043, 3/4)
although there are no common descriptors among these two
methods. Genetic algorithm kNN-MFA method have better
q2 (0.6790) and pred_r2 (0.7339) than other method, model
validation correctly predicts activity 68% and 73.3% for the
training and test set respectively.
k nearest neighbor ¼ 4; Ntraining ¼ 27; Ntest ¼ 7; q2
¼ 0:6790; q2se ¼ 0:4382; pred r2
¼ 0:7339; pred r2se ¼ 0:3287:
From 3D-QSAR model, it is observed that electrostatic
descriptors like E_685 (20%) with negative coefﬁcient are
near the X position of the Uracil ring (Fig. 1e). This indicates
that negative electronic potential is required to increase activ-
ity and more electronegative substituents group is preferred in
that X position. Electrostatic descriptors like E_1022 with
positive coefﬁcients are at the X ring of Uracil structure indi-
cating that electropositive groups are favorable on this site andudy of uracil-based hydroxamic acids-containing histone deacetylase inhibitors.
Figure 1g Contribution plot for steric and electrostatic interactions SA-PLS model.
Molecular modeling study of histone deacetylase inhibitors 9the presence of electropositive groups would increase the his-
tone deacetylase inhibitors activity of these compounds. Most
of the compounds (compounds 1–6, 10–21, 25–34, etc.) with
higher activity having electropositive substitution at the X
position of uracil ring strongly support the above statement.
This indicates that that group that imparting positive electro-
static potential is favorable for activity so less electronegative
group is preferred in that region. The plots of Predicted versus
Observed values of pIC50 are shown in Fig. 1f). The presence
of steric descriptors S_1300 with negative coefﬁcients is also
near from the X position of the ring which indicates that less
bulky groups are unfavorable on this site and presence of less
bulky groups decreases the histone deacetylase inhibitors activ-
ity of Uracil compounds.
k nearest neighbor ¼ 4; Ntraining ¼ 27; Ntest ¼ 7; q2
¼ 0:6838; q2se ¼ 0:2165; pred r2
¼ 0:6343; pred r2se ¼ 0:5063
Model 6 (SA-kNN-MFA) is used for internal predictivity,
the value of LOO cross-validation squared correlation coefﬁ-
cient suggested goodness of the prediction. It is observed that
steric, electrostatic descriptors like S_723 and E_1601 withFigure 1h Best molecules
Please cite this article in press as: Sharma, M.C., Sharma, S. Molecular modeling st
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(Fig. 1g). The observed and the predicted biological activity
obtained using k-nearest neighbor model for the training and
the test set compounds are shown in Table 5.
We were generated different pharmacophore patterns based
on a set thirty-four aligned molecules. Selected pharma-
cophore shows four chemical features which were present in
all 34 molecules. The information shows that the four features
used were one AroC feature (Aromatic), one AlaC (aliphatic)
and two HAc (Hydrogen bond acceptor) features. The average
RMSD of the pharmacophore alignment of each two mole-
cules is 0.0754 A˚ (Fig. 1h).
4. Conclusion
The genetic algorithm and simulated annealing are applied to
the optimization and selection of suitable descriptors for the
development of QSAR models for uracil based derivatives.
The objective of the present multiple QSAR investigations
was to develop Pharmacophore, 3D QSAR models based on
similarity indices and 2D QSAR models based on classical
descriptors. The QSAR studies results obtained from the study
provide signiﬁcant statistical parameters and various valida-pharmacophore sites.
udy of uracil-based hydroxamic acids-containing histone deacetylase inhibitors.
10 M.C. Sharma, S. Sharmation studies conﬁrm that the training set models 1–6 are statis-
tically reliable and robust. The 2D-QSAR model reported
herein provides some interesting insight into understanding
the electrotopological descriptors, molecular connectivity
descriptors and hydrophobicity descriptor are contributed sig-
niﬁcantly for the stability of the models. Presence of methoxy
groups at R position of uracil moiety favored the activity. This
consideration led us to further develop partial least squares
analysis models with classical descriptors.
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